MMP-2 and sTNF-R1 Variability in Patients with Essential Hypertension: 1-Year Follow-Up Study

Abstract

The aim of this study is to analyze MMP-2 and sTNF-R1 variability, potent predictors of cardiovascular events, in stable hypertensive patients during a 12-month followup. 234 asymptomatic patients (age 60 ± 13, 136 male) out of 252 patients with essential hypertension were followed up. MMP-2 and sTNF-R1 were measured at baseline and after 12 months (stage I). To compare MMP-2 and sTNF-R1 levels over time interval, we used the statistical method of Bland-Altman. MMP-2 and sTNF-R1 reproducibility was good in our patients for the two intervals with a coefficient of reproducibility of 8.2% and 11.3%, respectively. The percentages of patients within 1.96 × standard deviation of the mean were 93.6% and 92.7%. An elevated coefficient of correlation was obtained for MMP-2, basal versus stage I (r = 0.55, P < 0.0001) and for sTNF-R1 (r = 0.75, P < 0.0001). There is good stability in MMP-2 and sTNF-R1 levels in a followup study of patients with stable hypertension. As a consequence, assessment of its concentrations may be a useful tool for monitoring the follow-up of these patients. Measured variations in MMP-2 and sTNF-R1 levels, exceeding 8.2% and 11.3%, respectively, may indicate an increase in cardiovascular risk, thus, could be used to optimizing treatment than blood pressure control alone.

Educational level and chronic inflammation in the elderly – the role of obesity: results from the population‐based CARLA study

“…As a major inflammation component, the tumour necrosis factor alpha (TNF‐alpha) system seems to be involved in several pathways leading to adverse alterations of tissues . Nevertheless, temporal fluctuations of TNF‐alpha make it difficult to assess chronic inflammation by measuring blood levels of this parameter . The soluble TNF‐alpha type 1 and 2 receptors (sTNF‐R1/2) were found to be temporally stable markers of TNF‐alpha activity , thus making them useful surrogate markers of chronic inflammation.…”

“…Nevertheless, temporal fluctuations of TNF‐alpha make it difficult to assess chronic inflammation by measuring blood levels of this parameter . The soluble TNF‐alpha type 1 and 2 receptors (sTNF‐R1/2) were found to be temporally stable markers of TNF‐alpha activity , thus making them useful surrogate markers of chronic inflammation. The prognostic relevance of soluble TNF receptors in cardiovascular diseases was revealed by several previous studies .…”

Inflammation and Renal Function after a Four-Year Follow-Up in Subjects with Unimpaired Glomerular Filtration Rate: Results from the Observational, Population-Based CARLA Cohort

“…In particular, the soluble tumour necrosis factor receptor type 1 (sTNF-R1) was found to correlate remarkably with Cystatin C in a cross-sectional analysis [4] , [5] . The stability of sTNF-R1 makes it an easily assessable marker of the larger TNF system [6] . In a longitudinal analysis of patients with type 2 diabetes sTNF-R1 [7] and the second type of soluble tumour necrosis factor receptor (sTNF-R2) [7] , [8] were associated with a decline in glomerular filtration rate (GFR), which was similar to findings in a population-based cohort [9] .…”

Inflammation and echocardiographic parameters of ventricular hypertrophy in a cohort with preserved cardiac function

“…The stability of sTNF-R1 makes it an easily assessable marker of the larger TNF system. 13 Interestingly, the type 1 receptor of TNF-α is the origin of several pathways in the human heart, affecting cell metabolism, apoptosis and remodelling. 2 The soluble form of this receptor is released from its membrane-bound component by different stimuli (eg, TNF-α, lipopolysaccharides), and serves among other things as a ligand to TNF-α.…”